133 related articles for article (PubMed ID: 21593513)
1. The natural history of treated Parkinson's disease in an incident, community based cohort.
Evans JR; Mason SL; Williams-Gray CH; Foltynie T; Brayne C; Robbins TW; Barker RA
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1112-8. PubMed ID: 21593513
[TBL] [Abstract][Full Text] [Related]
2. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
Pagano G; Taylor KI; Anzures Cabrera J; Simuni T; Marek K; Postuma RB; Pavese N; Stocchi F; Brockmann K; Svoboda H; Trundell D; Monnet A; Doody R; Fontoura P; Kerchner GA; Brundin P; Nikolcheva T; Bonni A; ;
Nat Med; 2024 Apr; 30(4):1096-1103. PubMed ID: 38622249
[TBL] [Abstract][Full Text] [Related]
3. Visual function changes in a Parkinson's Disease cohort - preliminary data.
Suciu VI; Suciu CI; Nicoară SD; Perju-Dumbravă L
Rom J Ophthalmol; 2021; 65(3):241-246. PubMed ID: 35036644
[TBL] [Abstract][Full Text] [Related]
4. Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
Gonzalez-Robles C; Weil RS; van Wamelen D; Bartlett M; Burnell M; Clarke CS; Hu MT; Huxford B; Jha A; Lambert C; Lawton M; Mills G; Noyce A; Piccini P; Pushparatnam K; Rochester L; Siu C; Williams-Gray CH; Zeissler ML; Zetterberg H; Carroll CB; Foltynie T; Schrag A;
J Parkinsons Dis; 2023; 13(6):1011-1033. PubMed ID: 37545260
[TBL] [Abstract][Full Text] [Related]
5. Early constipation predicts faster dementia onset in Parkinson's disease.
Camacho M; Macleod AD; Maple-Grødem J; Evans JR; Breen DP; Cummins G; Wijeyekoon RS; Greenland JC; Alves G; Tysnes OB; Lawson RA; Barker RA; Williams-Gray CH
NPJ Parkinsons Dis; 2021 May; 7(1):45. PubMed ID: 34039994
[TBL] [Abstract][Full Text] [Related]
6. Combining biomarkers for prognostic modelling of Parkinson's disease.
Vijiaratnam N; Lawton M; Heslegrave AJ; Guo T; Tan M; Jabbari E; Real R; Woodside J; Grosset K; Chelban V; Athauda D; Girges C; Barker RA; Hardy J; Wood N; Houlden H; Williams N; Ben-Shlomo Y; Zetterberg H; Grosset DG; Foltynie T; Morris HR;
J Neurol Neurosurg Psychiatry; 2022 May; 93(7):707-15. PubMed ID: 35577512
[TBL] [Abstract][Full Text] [Related]
7. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
Williams-Gray CH; Mason SL; Evans JR; Foltynie T; Brayne C; Robbins TW; Barker RA
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1258-64. PubMed ID: 23781007
[TBL] [Abstract][Full Text] [Related]
8. Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study.
Reinoso G; Allen JC; Au WL; Seah SH; Tay KY; Tan LC
Eur J Neurol; 2015 Mar; 22(3):457-63. PubMed ID: 24888502
[TBL] [Abstract][Full Text] [Related]
9. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients.
Auyeung M; Tsoi TH; Mok V; Cheung CM; Lee CN; Li R; Yeung E
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):607-11. PubMed ID: 22362919
[TBL] [Abstract][Full Text] [Related]
10. Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort.
Kim HJ; Mason S; Foltynie T; Winder-Rhodes S; Barker RA; Williams-Gray CH
Mov Disord; 2020 Jan; 35(1):185-190. PubMed ID: 31965629
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
; Gray R; Ives N; Rick C; Patel S; Gray A; Jenkinson C; McIntosh E; Wheatley K; Williams A; Clarke CE
Lancet; 2014 Sep; 384(9949):1196-205. PubMed ID: 24928805
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes.
Zarkali A; Hannaway N; McColgan P; Heslegrave AJ; Veleva E; Laban R; Zetterberg H; Lees AJ; Fox NC; Weil RS
Brain Commun; 2024; 6(3):fcae130. PubMed ID: 38715714
[TBL] [Abstract][Full Text] [Related]
13. Gait impairment-related axonal degeneration in Parkinson's disease by neurite orientation dispersion and density imaging.
Wei X; Wang S; Zhang M; Yan Y; Wang Z; Wei W; Tuo H; Wang Z
NPJ Parkinsons Dis; 2024 Feb; 10(1):45. PubMed ID: 38413647
[TBL] [Abstract][Full Text] [Related]
14. Ketogenic diet-produced β-hydroxybutyric acid accumulates brain GABA and increases GABA/glutamate ratio to inhibit epilepsy.
Qiao YN; Li L; Hu SH; Yang YX; Ma ZZ; Huang L; An YP; Yuan YY; Lin Y; Xu W; Li Y; Lin PC; Cao J; Zhao JY; Zhao SM
Cell Discov; 2024 Feb; 10(1):17. PubMed ID: 38346975
[TBL] [Abstract][Full Text] [Related]
15. Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study.
Lin J; Ou R; Li C; Hou Y; Zhang L; Wei Q; Pang D; Liu K; Jiang Q; Yang T; Xiao Y; Zhao B; Chen X; Song W; Yang J; Wu Y; Shang H
BMC Med; 2023 Nov; 21(1):420. PubMed ID: 37932720
[TBL] [Abstract][Full Text] [Related]
16. KSNR Clinical Consensus Statements: Rehabilitation of Patients with Parkinson's Disease.
; Kim DY; Oh HM; Bok SK; Chang WH; Choi Y; Chun MH; Han SJ; Han TR; Jee S; Jung SH; Jung HY; Jung TD; Kim MW; Kim EJ; Kim HS; Kim YH; Kim Y; Kim DY; Kim DY; Kim DK; Ko SH; Ko MH; Lee JK; Lee J; Lee SJ; Lee SG; Lim SH; Oh BM; Paik NJ; Park KD; Park SW; Park GY; Park JH; Park YG; Pyun SB; Ryu B; Seo HG; Shin YI; Sohn MK; Yang SN; Don Yoo S; Yoo WK
Brain Neurorehabil; 2020 Jul; 13(2):e17. PubMed ID: 36744191
[TBL] [Abstract][Full Text] [Related]
17. Onset of Postural Instability in Parkinson's Disease Depends on Age rather than Disease Duration.
Becker D; Maric A; Schreiner SJ; Büchele F; Baumann CR; Waldvogel D
Parkinsons Dis; 2022; 2022():6233835. PubMed ID: 36506486
[TBL] [Abstract][Full Text] [Related]
18. The Role of Ketogenic Diet in the Treatment of Neurological Diseases.
Dyńka D; Kowalcze K; Paziewska A
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501033
[TBL] [Abstract][Full Text] [Related]
19. Multidimensional Assessment of Individuals with Parkinson's Disease: Development and Structure Validation of a Self-Assessment Questionnaire.
Mendes LC; Marques IA; Alves CM; Vieira MF; Júnior EAL; Pereira AA; Naves ELM; Oliveira FHM; Bourhis G; Pino P; Morère Y; Andrade AO
Healthcare (Basel); 2022 Sep; 10(10):. PubMed ID: 36292272
[TBL] [Abstract][Full Text] [Related]
20. Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulation.
Zampogna A; Cavallieri F; Bove F; Suppa A; Castrioto A; Meoni S; Pélissier P; Schmitt E; Bichon A; Lhommée E; Kistner A; Chabardès S; Seigneuret E; Fraix V; Moro E
NPJ Parkinsons Dis; 2022 Sep; 8(1):121. PubMed ID: 36153351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
